SCHEMBL21996265

SCHEMBL21996265

CC(C)(C)OC(=O)N(F)Cc1ccc(CO)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
GPR119 Q8TDV5 1/20 0.38
KDM1A O60341 2/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
SSTR4 P31391 1/20 0.37
AKT1 P31749 2/20 0.37
GRM2 Q14416 1/20 0.36
CTSL P07711 2/20 0.36
CTSB P07858 2/20 0.36
CTSS P25774 2/20 0.36
RIPK1 Q13546 2/20 0.35
EPHX2 P34913 1/20 0.35
NR1D1 P20393 1/20 0.34
KCNQ4 P56696 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1935308 0.82 PPARG (0.46) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL3745549 0.78 HDAC3 (0.60) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL20746779 0.78 GPR119 (0.41) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL14829724 0.78 PPARG (0.43) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL17091111 0.78 GABRA5 (0.39) HDAC3HDAC1HDAC2NCOR2SSTR4
SCHEMBL21698542 0.77 GPR119 (0.40) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL1369160 0.77 HDAC3 (0.47) PPARGPPARAHDAC3HDAC1HDAC2
SCHEMBL1290160 0.77 AAK1 (0.44)
SCHEMBL16415871 0.76 HSD17B2 (0.43) HDAC3HDAC1HDAC2NCOR2
SCHEMBL18617678 0.76 GPR119 (0.47) PPARGPPARAHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3886854-A1 PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF Nuvation Bio Inc. (US) 2021-10-06 EP disclosed
US-11034669-B2 Pyrrole and pyrazole compounds and methods of use thereof NUVATION BIO INC. (BM) 2021-06-15 US disclosed
US-20200239433-A1 PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) 2020-07-30 US disclosed
WO-2020113094-A1 PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF NUVATION BIO INC. (US) 2020-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239433-A1 PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF NCOA3, NCOA1, NR3C1 PPARG 12/4885PPARA 13/4885HDAC3 702/4885
US-11034669-B2 Pyrrole and pyrazole compounds and methods of use thereof NCOA3, NCOA1, NR3C1 PPARG 12/4885PPARA 13/4885HDAC3 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.